NASDAQ
XLABW
Last Price
US $0.5901
Valuation
Financial
Performance
Cash flow to debt coverage
Exascale Labs Holdings Inc. Warrant balance-sheet data unavailable; cash-flow debt coverage cannot be computed.
Free cash flow growth
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Debt-to-equity ratio
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Debt-to-equity trend
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Net debt to EBITDA
Exascale Labs Holdings Inc. Warrant has negative EBITDA, making leverage ratio unreliable
Interest coverage
Exascale Labs Holdings Inc. Warrant interest expense data unavailable for the most recent period; interest coverage ratio cannot be reliably computed.
Profit margin growth
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Current ratio
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Return on assets
Exascale Labs Holdings Inc. Warrant's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Return on equity
Exascale Labs Holdings Inc. Warrant's return on equity of 0.00%, is lower than 15.00%, indicating bad performance
Earnings quality
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Earnings stability
Exascale Labs Holdings Inc. Warrant has insufficient public price history to evaluate earnings stability.
Positive free cash flow
Exascale Labs Holdings Inc. Warrant has negative free cash flow, indicating the company is burning cash rather than generating it
Free cash flow yield
Exascale Labs Holdings Inc. Warrant has a free cash flow yield of 0.00%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Earnings growth
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Revenue growth
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Return on invested capital
ROIC is unavailable for Exascale Labs Holdings Inc. Warrant; this check cannot be evaluated.
3-year revenue CAGR
Exascale Labs Holdings Inc. Warrant has insufficient revenue history to calculate 3-year revenue CAGR.
Revenue consistency
Exascale Labs Holdings Inc. Warrant has insufficient public price history to evaluate revenue consistency.
Return on equity consistency
Exascale Labs Holdings Inc. Warrant has insufficient public price history to evaluate ROE consistency.
Cash Flow Valuation (DCF)
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
Earnings yield (TTM)
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
EBITDA Valuation
Exascale Labs Holdings Inc. Warrant has insufficient data to evaluate this check.
EV/EBITDA (FY)
Exascale Labs Holdings Inc. Warrant has negative or missing EBITDA, making EV/EBITDA ratio unreliable
PEG ratio (TTM/FY)
Exascale Labs Holdings Inc. Warrant has insufficient data to calculate the PEG ratio.
Price-to-book ratio (FY)
Exascale Labs Holdings Inc. Warrant has negative shareholder equity; price-to-book is not meaningful and the check fails
Price-to-sales ratio (TTM)
Exascale Labs Holdings Inc. Warrant has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue
Profit margin
Current Ratio
Capital Returns
Valuation History
Cash flow
Profit margin
-
Fair Value
Market $0.5901
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.